Works matching IS 11738804 AND DT 1999 AND VI 11 AND IP 3

Results: 7

Antiretroviral Drug Guidelines for the Treatment of HIV Infection: Should Protease Inhibitors Always be Included in the Initial Regimen or Not?

Published in:

BioDrugs, 1999, v. 11, n. 3, p. 147, doi. 10.2165/00063030-199911030-00001

By:

Churchill, D.;
Weber, J.

Publication type:

Article

Appropriate Use of Interferon Beta-1a in Multiple Sclerosis.

Published in:

BioDrugs, 1999, v. 11, n. 3, p. 155, doi. 10.2165/00063030-199911030-00002

By:

Jacobs, L.;
Brownscheidle, C.M.

Publication type:

Article

Cytokine-Based Approaches to the Treatment of Multidrug-Resistant Tuberculosis.

Published in:

BioDrugs, 1999, v. 11, n. 3, p. 165, doi. 10.2165/00063030-199911030-00003

By:

Condos, R.;
Schluger, N.W.

Publication type:

Article

Optimal Use of Epoetin-α in the Anaemia of Chronic Renal Failure.

Published in:

BioDrugs, 1999, v. 11, n. 3, p. 175, doi. 10.2165/00063030-199911030-00004

By:

Ifudu, O.

Publication type:

Article

Treatment of Drug-Induced Agranulocytosis with Haematopoietic Growth Factors: A Review of the Clinical Experience.

Published in:

BioDrugs, 1999, v. 11, n. 3, p. 185, doi. 10.2165/00063030-199911030-00005

By:

Vial, T.;
Gallant, C.;
Choqu-Kastylevsky, G.;
descotes, J.

Publication type:

Article

Recent Advances in Anti-Tumour Necrosis Factor (TNF) Therapy in Rheumatoid Arthritis: Focus on the Soluble TNF Receptor p75 Fusion Protein, Etanercept.

Published in:

BioDrugs, 1999, v. 11, n. 3, p. 201, doi. 10.2165/00063030-199911030-00006

By:

Moreland, L.W.

Publication type:

Article

Potential Clinical Applications of Recombinant Human Haemoglobin in Blood Conservation.

Published in:

BioDrugs, 1999, v. 11, n. 3, p. 211, doi. 10.2165/00063030-199911030-00007

By:

Leone, B.J.

Publication type:

Article